It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.
CVS unveils AI platform raises 2025 forecast, projecting $400B revenue and improved earnings to enhance consumer healthcare experience.
Dec 9 (Reuters) - CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, ...
CVS Health shares climbed Tuesday after the health conglomerate hiked its full-year outlook and outlined plans for a new AI ...
As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...
CVS Health’s Aetna health insurance unit said it will “integrate pharmacy prescriptions and medical procedures into a single ...
CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback